Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Bayle

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 27, 2017
Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitorsAndrii Monastyrskyi, Simon Bayle, Victor Quereda, et al.
Environmental Science & Technology|July 7, 2023
Uranium Speciation in a Chalky SoilSimon Bayle, Maria Rosa Beccia, Christophe Moulin, et al.
Cancer Cell|November 1, 2019
Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast CancerVictor Quereda, Simon Bayle, Francesca Vena, et al.
Oncogene|August 29, 2024
Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related SchwannomatosisMaria A González-Rodriguez, Scott Troutman, Simon Bayle, et al.
Inorganic Chemistry|April 1, 2026
Unveiling the Stability and Kinetic Pathway from Plutonium Clusters to Colloidal PuO<sub>2</sub> NanoparticlesMaëva Munoz, Christelle Tamain, Matthieu Virot, et al.
Chemical Communications (Cambridge, England)|May 9, 2024
Chronicles of plutonium peroxides: spectroscopic characterization of a new peroxo compound of Pu(IV)Julien Margate, Simon Bayle, Thomas Dumas, et al.
Ultrasonics Sonochemistry|April 13, 2025
Unveiling the dual reactivity of nanoscaled PuO<sub>2</sub> sonicated in oxygenated aqueous solutionsJulien Margate, Matthieu Virot, Thomas Dumas, et al.
Journal of Medicinal Chemistry|May 19, 2023
Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δJun Yong Choi, Yoshihiko Noguchi, James M Alburger, et al.
European Journal of Medicinal Chemistry|January 17, 2024
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo propertiesAlisa Morozova, Sean Chin Chan, Simon Bayle, et al.
Molecular Cancer Therapeutics|May 21, 2020
Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine KinaseFrancesca Vena, Simon Bayle, Ainhoa Nieto, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|December 27, 2017
Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitorsAndrii Monastyrskyi, Simon Bayle, Victor Quereda, et al.
Environmental Science & Technology|July 7, 2023
Uranium Speciation in a Chalky SoilSimon Bayle, Maria Rosa Beccia, Christophe Moulin, et al.
Cancer Cell|November 1, 2019
Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast CancerVictor Quereda, Simon Bayle, Francesca Vena, et al.
Oncogene|August 29, 2024
Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related SchwannomatosisMaria A González-Rodriguez, Scott Troutman, Simon Bayle, et al.
Inorganic Chemistry|April 1, 2026
Unveiling the Stability and Kinetic Pathway from Plutonium Clusters to Colloidal PuO<sub>2</sub> NanoparticlesMaëva Munoz, Christelle Tamain, Matthieu Virot, et al.
Chemical Communications (Cambridge, England)|May 9, 2024
Chronicles of plutonium peroxides: spectroscopic characterization of a new peroxo compound of Pu(IV)Julien Margate, Simon Bayle, Thomas Dumas, et al.
Ultrasonics Sonochemistry|April 13, 2025
Unveiling the dual reactivity of nanoscaled PuO<sub>2</sub> sonicated in oxygenated aqueous solutionsJulien Margate, Matthieu Virot, Thomas Dumas, et al.
Journal of Medicinal Chemistry|May 19, 2023
Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δJun Yong Choi, Yoshihiko Noguchi, James M Alburger, et al.
European Journal of Medicinal Chemistry|January 17, 2024
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo propertiesAlisa Morozova, Sean Chin Chan, Simon Bayle, et al.
Molecular Cancer Therapeutics|May 21, 2020
Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine KinaseFrancesca Vena, Simon Bayle, Ainhoa Nieto, et al.
Pageof 2